aprindine has been researched along with Diabetic Angiopathies in 1 studies
Aprindine: A class Ib anti-arrhythmia agent used to manage ventricular and supraventricular arrhythmias.
Diabetic Angiopathies: VASCULAR DISEASES that are associated with DIABETES MELLITUS.
Excerpt | Relevance | Reference |
---|---|---|
"A multicenter, placebo-controlled, randomized, double-blind trial compared the preventive effect of aprindine and digoxin on the recurrence of atrial fibrillation (AF) with placebo, and also compare the effectiveness of these 2 drugs in the prevention of AF." | 9.10 | Double-blind placebo-controlled trial of aprindine and digoxin for the prevention of symptomatic atrial fibrillation. ( Atarashi, H; Fukunami, M; Hamada, C; Inoue, H; Origasa, H; Sugi, K, 2002) |
"A multicenter, placebo-controlled, randomized, double-blind trial compared the preventive effect of aprindine and digoxin on the recurrence of atrial fibrillation (AF) with placebo, and also compare the effectiveness of these 2 drugs in the prevention of AF." | 5.10 | Double-blind placebo-controlled trial of aprindine and digoxin for the prevention of symptomatic atrial fibrillation. ( Atarashi, H; Fukunami, M; Hamada, C; Inoue, H; Origasa, H; Sugi, K, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atarashi, H | 1 |
Inoue, H | 1 |
Fukunami, M | 1 |
Sugi, K | 1 |
Hamada, C | 1 |
Origasa, H | 1 |
1 trial available for aprindine and Diabetic Angiopathies
Article | Year |
---|---|
Double-blind placebo-controlled trial of aprindine and digoxin for the prevention of symptomatic atrial fibrillation.
Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Coronary Disease; Diabetic Angiopathie | 2002 |